Merino, Jose G. MD, MPhil; Editor-in-Chief, Neurology(R)
doi : 10.1212/WNL.0000000000013197
Volume 98(6), 8 February 2022, p 217-218
Tannous, Jonika PhD; Vahidy, Farhaan S. PhD, MBBS, MPH
doi : 10.1212/WNL.0000000000013196
Volume 98(6), 8 February 2022, p 219-220
McKeon, Andrew MD
doi : 10.1212/WNL.0000000000013089
Volume 98(6), 8 February 2022, p 221-222
Velek, Premysl MSc; Splinter, Marije J. MSc; Ikram, M. Kamran PhD; Ikram, M. Arfan PhD; Leening, Maarten J.G. PhD; van der Lei, Johan PhD; olde Hartman, Tim PhD; Peters, Lilian L. PhD; Tange, Huibert PhD; Rutten, Frans H. PhD; van Weert, Henk PhD; Wolters, Frank J. PhD; Bindels, Patrick J.E. PhD; Licher, Silvan PhD; de Schepper, Evelien I.T. PhD
doi : 10.1212/WNL.0000000000013145
Volume 98(6), 8 February 2022, p e564-e572
Although there is evidence of disruption in acute cerebrovascular and cardiovascular care during the coronavirus disease 2019 (COVID-19) pandemic, its downstream effect in primary care is less clear. We investigated how the pandemic affected utilization of cerebrovascular and cardiovascular care in general practices (GPs) and determined changes in GP-recorded diagnoses of selected cerebrovascular and cardiovascular outcomes.
Jacob, Mina A. MD; Ekker, Merel S. MD; Allach, Youssra BsC; Cai, Mengfei MD; Aarnio, Karoliina MD; Arauz, Antonio MD; Arnold, Marcel MD; Bae, Hee-Joon MD; Bandeo, Lucrecia MD; Barboza, Miguel A. MD; Bolognese, Manuel MD; Bonardo, Pablo MD; Brouns, Raf MD; Chuluun, Batnairamdal MD; Chuluunbatar, Enkhzaya MD; Cordonnier, Charlotte MD; Dagvajantsan, Byambasuren MD; Debette, Stephanie MD; Don, Adi MD; Enzinger, Chris MD; Ekizoglu, Esme MD; Fandler-Hofler, Simon MD; Fazekas, Franz MD; Fromm, Annette MD; Gattringer, Thomas MD; Hora, Thiago F. MD; Jern, Christina MD; Jood, Katarina MD; Kim, Young Seo MD; Kittner, Steven MD; Kleinig, Timothy MD; Klijn, Catharina J.M. MD; Korv, Janika MD; Kumar, Vinod MD; Lee, Keon-Joo MD; Lee, Tsong-Hai MD; Maaijwee, Noortje A.M. MD; Martinez-Majander, Nicolas MD; Marto, Joao P. MD; Mehndiratta, Man M. MD; Mifsud, Victoria MD; Montanaro, Vinicius MD; Pacio, Gisele MD; Patel, Vinod B. MD; Phillips, Matthew C. MD; Piechowski-Jozwiak, Bartlomiej MD; Pikula, Aleksandra MD; Ruiz-Sandoval, Jose MD; von Sarnowski, Bettina MD; Swartz, Richard H. MD; Tan, Kay-Sin MD; Tanne, David MD; Tatlisumak, Turgut MD; Thijs, Vincent MD; Viana-Baptista, Miguel MD; Vibo, Riina MD; Wu, Teddy Y. MD; Yesilot, Nilufer MD; Waje-Andreassen, Ulrike MD; Pezzini, Alessandro MD; Putaala, Jukka MD; Tuladhar, Anil M. MD; de Leeuw, Frank-Erik MD
doi : 10.1212/WNL.0000000000013195
Volume 98(6), 8 February 2022, p e573-e588
There is a worldwide increase in the incidence of stroke in young adults, with major regional and ethnic differences. Advancing knowledge of ethnic and regional variation in causes and outcomes will be beneficial in implementation of regional health care services. We studied the global distribution of risk factors, causes, and 3-month mortality of young patients with ischemic stroke, by performing a patient data meta-analysis from different cohorts worldwide.
Lu, Wentian PhD; Richards, Marcus PhD; Werring, David FRCP, PhD; Bobak, Martin MD, PhD
doi : 10.1212/WNL.0000000000013171
Volume 98(6), 8 February 2022, p e589-e600
Evidence on timing of memory change after first and recurrent strokes is limited and inconsistent. We investigated memory trajectories before and after first and recurrent strokes in 18 European countries and tested whether the country-level acute stroke care was associated with memory change after stroke.
Renu, Arturo MD, PhD*; Laredo, Carlos MSc*; Rodriguez-Vazquez, Alejandro MD; Santana, Daniel MD; Werner, Mariano MD; Llull, Laura MD, PhD; Lopez-Rueda, Antonio MD; Urra, Xabier MD, PhD; Rudilosso, Salvatore MD, PhD; Obach, Victor MD; Amaro, Sergi MD, PhD; Chamorro, Angel MD, PhD
doi : 10.1212/WNL.0000000000013198
Volume 98(6), 8 February 2022, p e601-e611
The presence of postinterventional subarachnoid hyperdensities (SA-HD) is a relatively common finding after mechanical thrombectomy (MT). We aimed to assess the incidence, characteristics, clinical relevance, and predictors of SA-HD after MT as categorized through the use of postinterventional dual-energy CT (DE-CT).
Ferro, Doeschka A. MD, PhD; Kuijf, Hugo J. PhD; Hilal, Saima PhD; van Veluw, Susanne J. PhD; van Veldhuizen, Danielle MSc; Venketasubramanian, Narayanaswamy FRCP; Tan, Boon Yeow MMED; Biessels, Geert Jan MD, PhD; Chen, Christopher FRCP
doi : 10.1212/WNL.0000000000013140
Volume 98(6), 8 February 2022, p e612-e622
Cerebral cortical microinfarcts (CMIs) are a novel MRI marker of cerebrovascular disease (CeVD) that predicts accelerated cognitive decline. Presence of CMIs is known to be associated with global cortical atrophy, although the mechanism linking the two is unclear. Our primary objective was to examine the relation between CMIs and cortical atrophy and to establish possible perilesional atrophy surrounding CMIs. Our secondary objective was to examine the role of cortical atrophy in CMI-associated cognitive impairment.
Huo, Nan MD, PhD; Vemuri, Prashanthi PhD; Graff-Radford, Jonathan MD; Syrjanen, Jeremy MS; Machulda, Mary PhD; Knopman, David S. MD; Jack, Clifford R. Jr MD; Petersen, Ronald MD, PhD; Mielke, Michelle M. PhD
doi : 10.1212/WNL.0000000000013174
Volume 98(6), 8 February 2022, p e623-e632
The prevalence of midlife cardiovascular conditions and risk factors is higher in men than women. Associations between midlife cardiovascular conditions or risk factors and midlife cognitive decline have been reported, but few studies have assessed sex differences in these associations.
Letellier, Noemie PhD; Gutierrez, Laure-Anne MSc; Pilorget, Corinne PhD; Artaud, Fanny PhD; Descatha, Alexis PhD; Ozguler, Anna PhD; Goldberg, Marcel PhD; Zins, Marie PhD; Elbaz, Alexis PhD; Berr, Claudine PhD
doi : 10.1212/WNL.0000000000013146
Volume 98(6), 8 February 2022, p e633-e640
To our knowledge, no study has investigated the effect of exposure to formaldehyde on cognition in the general population. Our objective was to examine the association between occupational exposure to formaldehyde and cognitive impairment in middle-aged and young-old adults (>=45 years).
Yoon, Seo Yeon MD, PhD; Park, You Hyun MPH; Lee, Hyo Jeong MD; Kang, Dae Ryong PhD*; Kim, Yong Wook MD, PhD*
doi : 10.1212/WNL.0000000000012942
Volume 98(6), 8 February 2022, p e641-e652
Many previous studies, mostly performed in Western countries, on the effects of lifestyle factors on Parkinson disease (PD) used baseline lifestyle characteristics without directly accounting for changes in covariate values over time. The objective of this study was to evaluate the association of repeatedly measured lifestyle factors with PD risk in a Korean population.
Gravier-Dumonceau, Alice MD; Ameli, Roxana MD; Rogemond, Veronique PhD; Ruiz, Anne MsC; Joubert, Bastien MD, PhD; Muniz-Castrillo, Sergio MD; Vogrig, Alberto MD; Picard, Geraldine; Ambati, Aditya MD, PhD; Benaiteau, Marie MD; Rulquin, Florence MD; Ciron, Jonathan MD; Deiva, Kumaran MD, PhD; de Broucker, Thomas MD, PhD; Kremer, Laurent MD; Kerschen, Philippe MD; Sellal, Francois MD, PhD; Bouldoires, Bastien MD; Genet, Roxana MD; Biberon, Julien MD; Bigot, Adrien MD; Duval, Fanny MD; Issa, Nahema MD; Rusu, Elena-Camelia MD; Goudot, Mathilde MD; Dutray, Anais MD; Devoize, Jean Louis MD; Hopes, Lucie MD; Kaminsky, Anne-Laure MD; Philbert, Marion MD; Chanson, Eve MD; Leblanc, Amelie MD; Morvan, Erwan MD; Andriuta, Daniela MD; Diraison, Philippe MD; Mirebeau, Gabriel MD; Derollez, Celine MD; Bourg, Veronique MD; Bodard, Quentin MD; Fort, Clementine MD; Grigorashvili-Coin, Irina MD; Rieul, Guillaume MD; Molinier-Tiganas, Daniela MD; Bonnan, Mickael MD; Tchoumi, Thierry MD; Honnorat, Jerome MD, PhD*; Marignier, Romain MD, PhD*
doi : 10.1212/WNL.0000000000013087
Volume 98(6), 8 February 2022, p e653-e668
To report the clinical, biological, and imaging features and clinical course of a French cohort of patients with glial fibrillary acidic protein (GFAP) autoantibodies.
Wirth, Thomas MD, MS; Namer, Izzie Jacques MD, PhD; Monga, Ben PhD; Bund, Caroline MD PhD; Iosif, Andra Valentina MD; Gebus, Odile MD, MS; Montaut, Solveig MD, MS; Bogdan, Thomas MD; Robelin, Laura PhD; Renaud, Mathilde MD, PhD; Kremer, Stephane MD, PhD; Tranchant, Christine MD, PhD; Anheim, Mathieu MD, PhD
doi : 10.1212/WNL.0000000000013172
Volume 98(6), 8 February 2022, p 232-236
Nigrostriatal dopaminergic denervation (NSDD) remains poorly characterized in cerebellar multiple system atrophy (MSA-C). We aimed to study NSDD progression in MSA-C and evaluate the capacity for [123I]-FP-CIT-SPECT and parkinsonism to differentiate MSA-C from idiopathic late-onset cerebellar ataxia (ILOCA).
Jones, Lyell K. Jr MD; Gross, Robert A. MD, PhD
doi : 10.1212/WNL.0000000000013199
Volume 98(6), 8 February 2022, p 237
Artificial Intelligence and the Practice of Neurology in 2035: The Neurology Future Forecasting Series
doi : 10.1212/WNL.0000000000013200
Volume 98(6), 8 February 2022, p 238-245
High-quality health care delivery relies on a complex orchestration of the flow of patient data. Incorporating advanced artificial intelligence (AI) technologies into this delivery system has tremendous potential to improve health care, but also carries with it unique challenges. The nature of neurologic disease, and the current state of neurologic care delivery, makes this area of medicine well positioned for AI-driven innovation by 2035. Business, ethics, regulation, and medical education will need to evolve in concert. The information technology and data standards requirements for this potential transformation are underappreciated and will be a major driver of changes across the industry. Using AI on patient data to drive health care innovation to improve patients' lives as the primary goal will facilitate widespread acceptance and adoption of the practices required for a successful AI transformation in neurology. In planning the incorporation of AI into clinical practice, the tenets of rigorous research will need to be vigilantly applied to prevent unwarranted costs and inconveniences while promoting meaningful health outcomes.
Acosta, Lealani Mae MD, MPH
doi : 10.1212/WNL.0000000000013109
Volume 98(6), 8 February 2022, p 246-248
Malhotra, Kiran Preet MD*; Malhotra, Hardeep Singh DM*; Sahoo, Rasmi Ranjan DM; Gupta, Priyanka MD; Chand Chaudhary, Shyam MD
doi : 10.1212/WNL.0000000000013147
Volume 98(6), 8 February 2022, p 249-250
Decker, Jessica DO; Singh, Mini MD
doi : 10.1212/WNL.0000000000013142
Volume 98(6), 8 February 2022, p 251-255
Sakoda, Marissa MD; Sarhadi, Kasra MD, MPH; Weisner, P. Annie MD, PhD; Tierney, Shannon MD; Wang, Yujie MD
doi : 10.1212/WNL.0000000000013141
Volume 98(6), 8 February 2022, p e669-e674
Wang, Meng MD; Zhao, Shengqi MD; Hu, Yan MD; Zuo, Yuchao MD; Zhao, Peichao MD; Guo, Fuyou MD
doi : 10.1212/WNL.0000000000013106
Volume 98(6), 8 February 2022, p e675-e676
Xu, Yingying MD; Meng, Yujie Postgraduate; Wang, Ping MD; Sun, Lin MD; Xu, Shunliang MD
doi : 10.1212/WNL.0000000000013144
Volume 98(6), 8 February 2022, p e677-e678
Lewis, Ariane MD; Galetta, Steven MD
doi : 10.1212/WNL.0000000000013202
Volume 98(6), 8 February 2022, p 256
Hung, Sheng-Che
doi : 10.1212/WNL.0000000000013203
Volume 98(6), 8 February 2022, p 256
Itrat, Ahmed
doi : 10.1212/WNL.0000000000013204
Volume 98(6), 8 February 2022, p 256-257
Do you want to add Medilib to your home screen?